Nature and behavior of serum cytokines in type 1 autoimmune hepatitis

Digestive Diseases and Sciences

Volumn 45, Issue 5, 2000, Pages 1028-1035

  Czaja, Albert J ^a   Sievers, Corey ^a   Zein, Nizar N ^a  

^a MAYO CLINIC   (United States)

Author keywords

Autoimmune hepatitis; Cytokines; Immunoregulation

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; PREDNISONE;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOIMMUNE HEPATITIS; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DRUG EFFECT; FEMALE; HUMAN; IMMUNOREGULATION; MALE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; CYTOKINES; FEMALE; HEPATITIS, AUTOIMMUNE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-2; INTERLEUKIN-4; MALE; MIDDLE AGED; REFERENCE VALUES;

EID: 0034090806     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005506031717     Document Type: Article

References (38)

1. 1. Czaja AJ: Autoimmune hepatitis: Evolving concepts and treatment strategies. Dig Dis Sci 40:435-456, 1995
2. 2. Tilg H, Wilmer A, Vogel W, Herold M, Nolchen B, Judmaier G, Huber C: Serum levels of cytokines in chronic liver diseases. Gastroenterology 103:264-274, 1992
3. 3. Maggiore G, De Benedetti F, Massa M, Pignatti P, Martini A: Circulating levels of interleukin-6, interleukin-8, and tumor necrosis factor-α in children with autoimmune hepatitis. J Pediatr Gastroenterol Nutr 20:23-27, 1995
4. 4. Al-Wabel A, Al-Janadi M, Raziuddin S: Cytokine profile of viral and autoimmune chronic active hepatitis. J Allergy Clin Immunol 92:902-908, 1993
5. 5. Lohr HF, Schaak JF, Gerken G, Fleischer B, Dienes H-P, Meyer zum Buschenfelde K-H: Phenotypical analysis and cytokine release of liver-infiltrating and peripheral blood T lymphocytes from patients with chronic hepatitis of different etiology. Liver 14:161-166, 1994
6. 6. Schlaak JF, Lohr H, Gallati H, Meyer zum Buschenfelde K-H, Fleischer B: Analysis of the in vitro cytokine production by liver-infiltrating T cells of patients with autoimmune hepatitis. Clin Exp Immunol 94:168-173, 1993
7. 7. Trautwein C, Manns MP: Autoimmune hepatitis and cytokines. In Cytokines and the Liver. W Gerok, K Decker, T Andus, V Gross (eds). Dordrecht, The Netherlands, Kluwer Academic Publishers, 1995, pp 138-144
8. + T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today 16:34-38, 1995
9. 9. Lucey DR, Clerici M, Shearer GM: Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases. Clin Microbiol Rev 9:532-562, 1996
10. 10. Civeira M, Prieto J, Morte S, Rinon M, Serrano M: Interleukins in chronic active hepatitis B: relationship with viral markers. J Hepatol 5:37-44, 1987
11. 11. Anatassakos C, Alexander GJ, Wolsteneroft RA, Avery JA. Portmann BC, Panayi GS, Dumonde DC, Eddleston ALWF, Williams R: Interleukin-1 and interleukin-2 activity in chronic hepatitis B virus infection. Gastroenterology 94:999-1055, 1988
12. 12. Cacciarelli TV, Martinez OM, Gish RG, Villanueva JC, Krams SM: Immunoregulatory cytokines in chronic hepatitis C virus infection: Pre-and posttreatment with interferon alpha. Hepatology 24:6-9, 1996
13. 13. Bertoletti A, D'Elios MM, Boni C, De Carli M, Zignego AL, Durazzo M, Missale G, Penna A, Fiaccadori F, Del Prete G, Ferrari C: Different cytokine profiles of intrahepatic T cells in chronic hepatitis B and hepatitis C virus infections. Gastroenterology 112:193-199, 1997
14. 14. Peters M: Actions of cytokines on the immune response and viral interactions: An overview. Hepatology 23:909-916, 1996
15. 15. Bloom BR, Salgame P, Diamond B: Revisiting and revising suppressor T cells. Immunol Today 13:131-136, 1992
16. 16. Clerici M, Shearer GM: The Th1-Th2 hypothesis of HIV infection: New insights. Immunol Today 15:575-581, 1994
17. 17. Riches P, Gooding R, Millar BC, Rowbotlom AW: Influence of collection and separation of blood samples on plasma IL-1, IL-6 and TNF-α concentrations. J Immunol Methods 153:125-131, 1992
18. 18. Mire-Sluis AR, Gaines-Das R, Thorpe R: Immunoassays for detecting cytokines: What are they really measuring? J Immunol Methods 186:157-160, 1995
19. 19. Johnson PJ, McFarlane IG, Alvarez F, Bianchi FB, Bianchi L, Burroughs A, Chapman RW, Czaja AJ, Desmet V, Edleston ALWF, Gerber MA, Hoofnagle JH, Kakumu S, MacSween RNM, Maddrey WC, Manns MP, Meyer zum Buschenfelde K-H, Mieli-Vergani G, Portmann BC, Reed WD, Schalm SW, Scheuer PJ, Toda G, Tsuji T, Tygstrup N, Vergani D, Zeniya M: Meeting report. International Autoimmune Hepatitis Group. Hepatology 18:998-1005, 1993
20. 20. Czaja AJ, Manns MP: The validity and importance of subtypes of autoimmune hepatitis: A point of view. Am J Gastroenterol 90:1206-1211, 1995
21. 21. Czaja AJ: Diagnosis and therapy of autoimmune liver disease. Med Clin North Am 80:973-994, 1996
22. 22. Czaja AJ: Drug therapy in the management of type 1 autoimmune hepatitis. Drugs 57:49-68, 1999
23. 23. Summerskill WHJ, Korman MG, Ammon HV, Baggenstoss AH: Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared. Gut 16:876-883, 1975
24. 24. DiMagno EP, Corle D, O'Brien JF, Masnyk IJ, Go VLW, Aamodt R: Effect of long-term freezer storage, thawing, and refreezing on selected constituents of serum. Mayo Clin Proc 64:1226-1234, 1989
25. 25. Baggenstoss AH, Soloway RD, Summerskill WHJ, Elveback LR, Schoenfield LJ: Chronic active liver disease. The range of histologic lesions, their response to treatment, and evolution. Hum Pathol 3:183-198, 1972
26. 26. Czaja AJ, Carpenter HA: Sensitivity, specificity and predictability of biopsy interpretations in chronic hepatitis. Gastroenterology 105:1824-1832, 1993
27. 27. Moore K, O'Garra A, Malefyt R, Vieira P, Mosmann T: Interleukin-10. Annu Rev Immunol 11:165-190, 1993
28. 28. Eddleston ALWF, Williams R: The role of immunological mechanisms in chronic hepatitis. Ann Clin Res 8:162-173, 1976
29. 29. Vento S, Nouri-Aria KT, Eddleston ALWF: Immune mechanisms in autoimmune chronic active hepatitis. Scand J Gastroenterol (suppl 114) 20:91-103, 1985
30. 30. Leung JP, Martin MRJ, Szefler SJ, Sher ER, Ying S, Kay AB, Hamid Q: Dysregulation of interleukin 4, interleukin 5, and interferon γ gene expression in steroid-resistant asthma. J Exp Med 181:33-40, 1995
31. 31. Czaja AJ, Wang KK, Shiels MT, Katzmann JA: Oral pulse prednisone therapy after relapse of severe autoimmune chronic active hepatitis. A prospective randomized treatment trial evaluating clinical, biochemical, and lymphocyte subset responses. J Hepatol 17:180-186, 1993
32. + CD56 surface phenotype and a T helper type 1 profile of cytokine secretion in the liver of patients chronically infected with hepatitis B virus. J Immunol 152:3074-3087, 1994
33. 33. De Carli M, D'Elios MM, Mariotti S, Marcocci C, Pinchera A, Ricci M, Romagnani S, Del Prete G: Cytolytic T cells with Th1-like cytokine profile predominate in retroorbital lymphocytic infiltrates of Graves' ophthalmopathy. J Clin Endocrinol Metab 77:1120-1124, 1993
34. 34. Nagler A, Lanier LL, Phillips JH: The effects of IL-4 on human natural killer cells. A potent regulator of IL-2 activation and proliferation. J Immunol 141:2349-2351, 1988
35. 35. Martinez OM, Gibbons RS, Garovoy MR, Aronson FR: IL-4 inhibits IL-2 receptor expression and IL-2-dependent proliferation of human T-cells. J Immunol 144:2211-2215, 1990
36. 36. Swain SL: Lymphokines and the immune response: The central role of interleukin-2. Curr Opin Immunol 3:304-310, 1991
37. 37. Wadhwa M, Thorpe R: Cytokine immunoassays: Recommendations for standardization, calibration and validation. J Immunol Methods 219:1-5, 1998
38. 38. Ferrari C, Mondelli MU, Penna A, Fiaccadori F, Chisari FV: Functional characterization of cloned intrahepatic hepatitis B virus nucleoprotein-specific T helper lines. J Immunol 139:539-544, 1987